CompletedNCT05067244
MDMA with cognitive processing therapy for trauma-related stress
About this title
Read the official source — NCT05067244Medication studyAges 18+CanadaPTSD
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: October 4, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- Remedy
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT05067244
- Official title
Show the full official title
A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Remedy.
Did this study involve medication?
Yes. The study involved medication, including MDMA.
Who was this study for?
Listed age limits: from 18 years.
